Bone cell

Hydroxy vitamin D pools ia the blood and is transported on DBF to the kidney, where further hydroxylation takes place at C-1 or C-24 ia response to calcium levels. l-Hydroxylation occurs primarily ia the kidney mitochondria and is cataly2ed by a mixed-function monooxygenase with a specific cytochrome P-450 (52,179,180). 1 a- and 24-Hydroxylation of 25-hydroxycholecalciferol has also been shown to take place ia the placenta of pregnant mammals and ia bone cells, as well as ia the epidermis. Low phosphate levels also stimulate 1,25-dihydtoxycholecalciferol production, which ia turn stimulates intestinal calcium as well as phosphoms absorption. It also mobilizes these minerals from bone and decreases their kidney excretion. Together with PTH, calcitriol also stimulates renal reabsorption of the calcium and phosphoms by the proximal tubules (51,141,181—183). 

The Ca(Il) coaceatratioa ia blood is closely coatroUed aormal values He betweea 2.1 and 2.6 mmol/L (8.5—10.4 mg/dL) of semm (21). The free calcium ion concentration is near 1.2 mmol/L the rest is chelated with blood proteias or, to a lesser extent, with citrate. It is the free Ca(Il) ia the semm that determines the calcium balance with the tissues. The mineral phase of bone is essentially ia chemical equiUbrium with calcium and phosphate ions present ia blood semm, and bone cells can easily promote either the deposition or dissolution of the mineral phase by localized changes ia pH or chelating... 

PTH has a dual effect on bone cells, depending on the temporal mode of administration given intermittently, PTH stimulates osteoblast activity and leads to substantial increases in bone density. In contrast, when given (or secreted) continuously, PTH stimulates osteoclast-mediated bone resorption and suppresses osteoblast activity. Further to its direct effects on bone cells, PTH also enhances renal calcium re-absorption and phosphate clearance, as well as renal synthesis of 1,25-dihydroxy vitamin D. Both PTH and 1,25-dihydroxyvitamin D act synergistically on bone to increase serum calcium levels and are closely involved in the regulation of the calcium/phosphate balance. The anabolic effects of PTH on osteoblasts are probably both direct and indirect via growth factors such as IGF-1 and TGF 3. The multiple signal transduction... 

Figure 9.1. Thin section of compact bone from Schleswig (cf. Table 9.1), after application of a cell stain (methylene blue). Besides the bone cells, exogenous cellular material in the hollow spaces (shown by arrows) indicates previous microbial invasions.

Figure 7.2. Schematics of bone anatomy (a) the structure of a long bone demonstrating the distribution of the two different tissue structures, cortical and cancellous bone, and (b) the cells present in bone osteoblasts, bone-forming cells found on surfaces osteocytes, bone cells embedded in the mineralised matrix and osteoclasts, bone-removing cells.

Figure 7.5. Feedback diagram for skeletal mechanical regulation. When forces are applied to a whole bone, the stimulus that results is sensed by the bone cells in the tissue. The sensor cells then signal bone-forming and -removing cells to change the geometry and material properties of the bone.

MANOLAGAS s c (2000) Birth and death of bone cells basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 21 (2) 115-37. 

Bone is a porous tissue composite material containing a fluid phase, a calcified bone mineral, hydroxyapatite (HA), and organic components (mainly, collagen type). The variety of cellular and noncellular components consist of approximately 69% organic and 22% inorganic material and 9% water. The principal constiments of bone tissue are calcium (Ca ), phosphate (PO ), and hydroxyl (OH ) ions and calcium carbonate. There are smaller quantities of sodium, magnesium, and fluoride. The major compound, HA, has the formula Caio(P04)g(OH)2 in its unit cell. The porosity of bone includes membrane-lined capillary blood vessels, which function to transport nutrients and ions in bone, canaliculi, and the lacunae occupied in vivo by bone cells (osteoblasts), and the micropores present in the matrix. 

M usculoskeletal Effects. Accidental exposure of a worker to 241 Am resulted in histological signs of fibrosis, bone cell depletion, and bone marrow atrophy. Degenerative changes in bone have also been observed in animals acutely exposed to 241 Am via inhalation and intravenous administration. 

Long GJ, Rosen JF, Pounds JG. 1990. Cellular lead toxicity and metabolism in primary and clonal osteoblastic bone cells. Toxicol Appl Pharmacol 102 346-361. 

Bone is an extremely dense connective tissue that, in various shapes, constitutes the skeleton. Although it is one of the hardest structures in the body, bone maintains a degree of elasticity owing to its structure and composition. It possesses a hierarchical structure and, as most of the tissues, is nanostructured in fact, it is a nanoscaled composite of collagen (organic extracellular matrix) and hydroxycarbonate apatite, (HCA, bone mineral). This nanostructure is in intimate contact with the bone cells (several microns in size), which result (at the macroscopic level) in the bone tissue. Figure 12.2 shows the bone hierarchical ordering from the bone to the crystalline structure of HCA. 

The principal cells in bone are the osteoclasts and osteoblasts. Osteoclasts, the cells responsible for resorption of bone, are derived from hematopoietic stem cells. Osteoblasts are derived from local mesenchymal cells. They are the pivotal bone cell, responsible for bone formation. Skeletal tissues are remodelled throughout a lifetime, alternating resorption phases by osteoclasts with periods of intense collagen synthesis. This balance is under the control of mechanical and hormonal stimuli, which ensure the appropriate performance of the bone. Skeletal tissues have three... 

Schiraldi et al. [64] have developed this kind of material by combining silica particles and pHEMA. pHEMA is a biocompatible hydrogel that has been widely studied in the past decades due to its chemical-physical structure and mechanical properties. It has been widely used in ophthalmic prostheses (contact or intraocular lenses), vascular prostheses, drug delivery systems and soft-tissue replacement [65]. These authors have shown that by incorporating silica nanoparticles, the resulting hybrid material is highly biocompatible and promotes bone cell adhesion and proliferation of bone cells seeded on it.1 ... 

Antioxidants in fruits and vegetables including vitamin C and (3-carotene reduce oxidative stress on bone mineral density, in addition to the potential role of some nutrients such as vitamin C and vitamin K that can promote bone cell and structural formation (Lanham-New 2006). Many fruits and vegetables are rich in potassium citrate and generate basic metabolites to help buffer acids and thereby may offset the need for bone dissolution and potentially preserve bone. Potassium intake was significantly and linearly associated with markers of bone turnover and femoral bone mineral density (Macdonald and others 2005). 

Calcitonin lowers serum Ca2+ and Pi levels, primarily by inhibiting the process of bone resorption, but also by decreasing resorption of Pi and Ca2+ in the kidney. Calcitonin receptors are predictably found primarily on bone cells (osteoclasts) and renal cells, and generation of cAMP via adenylate cyclase activation plays a prominent role in hormone signal transduction. 

Effects of Estrogen and Agonist of Estrogen Receptor on Bone Cells... 

Bone cells contain estrogen receptors (Eriksen et al. 1988 Oursler et al. 1991 Vidal et al. 1999). Estrogens act directly on osteoblasts and affect cell pro-... 

Heymann D, Rousselle AV (2000) gpl30 Cytokine family and bone cells. Cytokine 12 1455-1468... 

NO is recognized as a mediator of bone cell metabolism, where it regulates osteoblast and osteoclast activity [141-143]. Osteoporosis, which frequently occurs in postmenopausal women, is a systemic skeletal disease associated with abnormal bone resorption. Addition of NO or NO donors to osteoclasts in vitro results in a reduction in bone resorption, whereas NO synthase inhibitors increase bone resorption, both in vitro and in vivo. Further research has shown that NO reduces bone resorption, via inhibition of the cysteine protease cathepsin K, which is believed to be a key protease in bone resorption. Most of the NO donors, i.e., nitroglycerin, 3-... 

Hydroxyapatite constitutes -65% of human bone by weight. There is another 18% collagen fiber which makes the bone flexible and more durable. Then, there is -10% genetic tissue (mostly living bone cells). This tissue carries the genetic code of the person or animal and unless it is in a denatured form, which also kills the bone, it is likely to be rejected in the body as a bone graft. Therefore, it is impossible to successfully implant living bone even from closely related donors. The remainder of bone is composed of capillaries, nerves, and so on. 

Neither autograft, allograft, nor other calcium phosphate bioceramic materials of which we are aware have these properties. Figure 9(a) shows living bone with healthy bone cells (gray) deposited by osteoblasts into the pores of our bioceramic (1-3). 

In other studies, mast cells have been shown to be abundant in the marrow of osteoporotic patients, and heparin, which is contained within the secretory granules of connective tissue (peritoneal)-type mast cells, has been shown to enhance bone resorption and to inhibit bone-cell replication and collagen synthesis in vitro [130]. Moreover, heparin is known to bind growth factors such as fibroblast growth factor and may therefore be important in limiting their availability [134], Taken together, these various studies suggest a possible involvement of mast cells in the homeostasis of bone, but much more work is needed before any definitive conclusions can be drawn. 

---